Profile Picture HHS ASPA

created May 29 2020

updated May 5 2021

Description

The COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for the Uninsured Program provides reimbursements on a rolling basis directly to eligible health care entities for claims that are attributed to the testing, treatment, and or vaccine administration of COVID-19 for uninsured individuals. The program is funded via the:
Families First Coronavirus Response Act (FFCRA) Relief Fund, which includes funds received from the Public Health and Social Services Emergency Fund, as appropriated in the FFCRCA (P.L. 116-127) and the Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139) (PPPHCEA), which each appropriated $1 billion to reimburse health care entities for conducting COVID-19 testing for the uninsured; and the Provider Relief Fund, which includes funds received from the Public Health and Social Services Emergency Fund, as appropriated in the Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136), which provides $100 billion in relief funds, including to hospitals and other health care entities on the front lines of the COVID-19 response and the PPPHCEA to reimburse health care entities for treating uninsured individuals with a COVID-19 diagnosis.
The PPPHCEA appropriated an additional $75 billion in relief funds and the Coronavirus Response and Relief Supplemental Appropriations (CRRSA) Act (P.L. 116-260) appropriated another $3 billion. Within the Provider Relief Fund, a portion of the funding will be used to support healthcare-related expenses attributable to the treatment of uninsured individuals with COVID-19.
Health care entities that have conducted COVID-19 testing of uninsured individuals for COVID-19 or provided treatment to uninsured individuals with a COVID-19 diagnosis on or after February 4, 2020, can request claims reimbursement through the program electronically and will be reimbursed generally at Medicare rates, subject to available funding.
This dataset represents the list of health care entities who have agreed to the Terms and Conditions and received claims reimbursement for COVID-19 testing of uninsured individuals, vaccine administration and treatment for uninsured individuals with a COVID-19 diagnosis.

Activity
Community Rating
Current value: 0 out of 5
Your Rating
Current value: 0 out of 5
Raters
0
Visits
46937
Downloads
10546
Comments
0
Contributors
0
Meta
Category
Administrative
Permissions
Public
Tags
provider relief fund, cares act, coronavirus, uninsured, health system, covid-19
Row Label
Provider
SODA2 Only
Yes
Common Core
Contact Name
HRSA Chief Data Officer
Contact Email
PRFdata@hrsa.gov
Publisher
HRSA
Bureau Code
009:15
Program Code
009:020
Geographic Coverage
US
Update Frequency
Weekly
Footnotes
Each row is a health care entity that has received claims reimbursement for the COVID-19 testing, treatment, and/or vaccine administration of uninsured individuals. If a bundled claim included both testing and treatment, then all bundled payments to that entity are captured under treatment. Claims paid for vaccine administration do not have any other services on the claim. This data portal will be updated as additional data becomes available.
This view cannot be displayed